• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塞库维林是一种对大鼠心脏和大脑受体具有非选择性的毒蕈碱拮抗剂。

Secoverine is a non-selective muscarinic antagonist on rat heart and brain receptors.

作者信息

Brunner F, Waelbroeck M, Christophe J

出版信息

Eur J Pharmacol. 1986 Aug 7;127(1-2):17-25. doi: 10.1016/0014-2999(86)90201-3.

DOI:10.1016/0014-2999(86)90201-3
PMID:3758175
Abstract

In an attempt to determine if the selectivity of secoverine observed in vivo and in isolated tissues might be due to selective association with muscarinic receptor subtypes, we analyzed the binding of secoverine to three different receptors with specific radioligands: rat cardiac receptors (M2 receptors with low affinity for atropine), and rat cerebral cortical M1 receptors and M2 receptors with high affinity for atropine. At concentrations up to 10(-6) M, secoverine interaction with muscarinic receptors was competitive and of high affinity (Ki 4.10(-9) M) for cardiac and brain receptors. A detailed analysis using, in addition to [3H]N-methylscopolamine, the agonist [3H]oxotremorine-M (selective for high affinity binding sites at cardiac receptors) and the M1-selective antagonist [3H]pirenzepine at brain receptors, revealed identical affinities towards both receptor types, making it unlikely that secoverine distinguished the different muscarinic receptor subtypes. At concentrations between 10(-6) and 10(-3) M, secoverine interaction with an additional receptor site resulted in profound changes of tracer kinetics, suggesting the formation of a ternary complex (secoverine-radioligand-muscarinic receptor). The potency of secoverine for provoking this allosteric interaction was both tracer- and tissue-dependent. It is concluded that secoverine does not differentiate between M1, brain M2 and cardiac M2 receptors or between cardiac receptors with high, low and very low affinity for agonists. At very high concentrations secoverine recognized an allosteric site on the muscarinic receptors and reduced the dissociation rates of the 3H-ligands.

摘要

为了确定在体内和离体组织中观察到的西维美林的选择性是否可能归因于与毒蕈碱受体亚型的选择性结合,我们用特异性放射性配体分析了西维美林与三种不同受体的结合:大鼠心脏受体(对阿托品亲和力低的M2受体),以及对阿托品亲和力高的大鼠大脑皮质M1受体和M2受体。在浓度高达10⁻⁶ M时,西维美林与毒蕈碱受体的相互作用具有竞争性,对心脏和脑受体具有高亲和力(Ki 4×10⁻⁹ M)。除了[³H]N-甲基东莨菪碱外,还使用激动剂[³H]氧代震颤素-M(对心脏受体的高亲和力结合位点具有选择性)和脑受体处的M1选择性拮抗剂[³H]哌仑西平进行详细分析,结果显示对两种受体类型的亲和力相同,这使得西维美林不太可能区分不同的毒蕈碱受体亚型。在10⁻⁶至10⁻³ M之间的浓度下,西维美林与另一个受体位点的相互作用导致示踪剂动力学发生深刻变化,表明形成了三元复合物(西维美林-放射性配体-毒蕈碱受体)。西维美林引发这种变构相互作用的效力既取决于示踪剂,也取决于组织。得出的结论是,西维美林不能区分M1、脑M2和心脏M2受体,也不能区分对激动剂具有高、低和极低亲和力的心脏受体。在非常高的浓度下,西维美林识别毒蕈碱受体上的一个变构位点,并降低了³H-配体的解离速率。

相似文献

1
Secoverine is a non-selective muscarinic antagonist on rat heart and brain receptors.塞库维林是一种对大鼠心脏和大脑受体具有非选择性的毒蕈碱拮抗剂。
Eur J Pharmacol. 1986 Aug 7;127(1-2):17-25. doi: 10.1016/0014-2999(86)90201-3.
2
Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.大鼠中枢神经系统中的毒蕈碱受体异质性。II. 由[3H]氧震颤素-M标记的脑受体对应于对激动剂具有极高亲和力的异质性M2受体。
Mol Pharmacol. 1987 Jul;32(1):100-8.
3
Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.通过抑制[3H]哌仑西平和[3H]喹核醇基苯甲酸酯与大鼠脑膜的结合来研究加拉明与毒蕈碱M1和M2受体的结合。
Mol Pharmacol. 1986 Jul;30(1):58-68.
4
Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.大鼠脑中毒蕈碱结合位点M1、M2以及非M1、非M2亚型的区域分布
J Pharmacol Exp Ther. 1990 Dec;255(3):1148-57.
5
Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.N-甲基东莨菪碱与脑毒蕈碱型乙酰胆碱受体的多重结合亲和力:与M1和M2受体亚型的区分
J Pharmacol Exp Ther. 1986 Aug;238(2):554-63.
6
On the interaction of gallamine with muscarinic receptor subtypes.
Eur J Pharmacol. 1990 Jul 3;182(2):335-45. doi: 10.1016/0014-2999(90)90292-e.
7
Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.兔肺、鸡心脏和NG108 - 15细胞中M4毒蕈碱结合位点的特性研究
Mol Pharmacol. 1990 Dec;38(6):805-15.
8
Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.甲苯磺酸溴苄铵优先结合大鼠心脏和大脑皮层中用[3H]氧震颤素M标记的毒蕈碱受体(SH或“高亲和力”受体)。
Eur J Pharmacol. 1989 Jan 24;160(1):117-24. doi: 10.1016/0014-2999(89)90660-2.
9
In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
J Recept Res. 1986;6(1):47-61. doi: 10.3109/10799898609073923.
10
Functional and binding studies with muscarinic M2-subtype selective antagonists.毒蕈碱M2亚型选择性拮抗剂的功能与结合研究
Br J Pharmacol. 1989 Sep;98(1):309-17. doi: 10.1111/j.1476-5381.1989.tb16896.x.

引用本文的文献

1
Allosteric drugs acting at muscarinic acetylcholine receptors.作用于毒蕈碱型乙酰胆碱受体的变构药物。
Neurochem Res. 2003 Apr;28(3-4):419-22. doi: 10.1023/a:1022888332221.